Table 2. Incident Cancer Cases and Incidence Rate of Cancer in Patients With HIV Infection 20 to 79 Years of Age in Korea, 2006-2018.
| Cancer type | Men | Women | ||
|---|---|---|---|---|
| No. | Incidence ratea (95% CI) | No. | Incidence ratea (95% CI) | |
| All cancers | 317 | 474.79 (422.5-501.5) | 44 | 543.82 (383.13-625.81) |
| AIDS-defining cancer | ||||
| Kaposi sarcoma | 20 | 29.960 (16.83-36.65) | 0 | 0 |
| Cervical cancer | 0 | 0 | 7 | 86.52 (22.42-119.22) |
| Non-Hodgkin lymphoma | 67 | 100.35 (76.32-112.61) | 6 | 74.16 (14.82-104.43) |
| Non–AIDS-defining cancer | ||||
| Brain and CNS cancer | 2 | 3.00 (0.00-5.11) | 1 | 12.36 (0.00-24.72) |
| Urinary tract cancer | 9 | 13.48 (4.67-17.97) | 0 | 0 |
| Breast cancer | 1 | 1.50 (0.00-3.00) | 4 | 49.44 (0.99-74.16) |
| Colorectal cancer | 28 | 41.94 (26.40-49.86) | 2 | 24.72 (0.00-42.20) |
| Esophagus | 3 | 4.49 (0.00-7.09) | 0 | 0 |
| Hodgkin lymphoma | 7 | 10.48 (2.72-14.45) | 1 | 12.36 (0.00-24.72) |
| Liver, bile duct, and pancreas cancer | 33 | 49.43 (32.56-58.03) | 6 | 74.16 (14.82-104.43) |
| Lung and tracheal cancer | 28 | 41.94 (26.40-49.86) | 3 | 37.08 (0.00-58.49) |
| Malignant immunoproliferative diseases | 5 | 7.49 (0.92-10.84) | 0 | 0 |
| Oropharyngeal cancer | 13 | 19.47 (8.89-24.87) | 0 | 0 |
| Stomach cancer | 30 | 44.93 (28.85-53.14) | 4 | 49.44 (0.99-74.16) |
| Thyroid cancer | 12 | 17.97 (7.80-23.16) | 5 | 61.80 (7.63-89.43) |
| Prostate cancer | 17 | 25.46 (13.36-31.64) | 0 | 0 |
| Anal cancer | 20 | 29.96 (16.83-36.65) | 0 | 0 |
| Others | 26 | 38.94 (23.97-46.58) | 5 | 61.80 (7.63-89.43) |
Abbreviation: CNS, central nervous system.
a
Per 100 000 person-years.